$RCKT Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in ROCKET PHARMACEUTICALS, INC..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in ROCKET PHARMACEUTICALS, INC.. Get notifications about new insider transactions in ROCKET PHARMACEUTICALS, INC. for free.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jun 21 2021 | RCKT | ROCKET PHARMACEUTI ... | Makker Gotham | Sell | S | 47.13 | 400 | 18,850 | 1,296,401 | 1.3 M to 1.3 M (-0.03 %) | |
Jun 21 2021 | RCKT | ROCKET PHARMACEUTI ... | Makker Gotham | Sell | S | 47.13 | 400 | 18,850 | 1,296,401 | 1.3 M to 1.3 M (-0.03 %) | |
Jun 21 2021 | RCKT | ROCKET PHARMACEUTI ... | Makker Gotham | Sell | S | 46.85 | 34,685 | 1,624,843 | 1,296,801 | 1.3 M to 1.3 M (-2.60 %) | |
Jun 21 2021 | RCKT | ROCKET PHARMACEUTI ... | Makker Gotham | Sell | S | 46.85 | 34,685 | 1,624,843 | 1,296,801 | 1.3 M to 1.3 M (-2.60 %) | |
Jun 16 2021 | RCKT | ROCKET PHARMACEUTI ... | SOUTHWELL DAVID P | Option Exercise | A | 47.25 | 12,236 | 578,151 | 12,236 | ||
May 13 2021 | RCKT | ROCKET PHARMACEUTI ... | RTW INVESTMENTS, LP | Director | Option Exercise | J | 40.03 | 1 | 40 | 1,000,000 | |
May 13 2021 | RCKT | ROCKET PHARMACEUTI ... | RTW INVESTMENTS, LP | Director | Sell | S | 40.03 | 725,000 | 29,023,490 | 15,460,119 | 16.2 M to 15.5 M (-4.48 %) |
Apr 01 2021 | RCKT | ROCKET PHARMACEUTI ... | Shah Gaurav | CEO | Payment of Exercise | F | 47.21 | 7,475 | 352,903 | 495,639 | 503.1 K to 495.6 K (-1.49 %) |
Apr 01 2021 | RCKT | ROCKET PHARMACEUTI ... | Shah Gaurav | CEO | Payment of Exercise | F | 46.45 | 8,872 | 412,075 | 503,114 | 512 K to 503.1 K (-1.73 %) |
Apr 01 2021 | RCKT | ROCKET PHARMACEUTI ... | Shah Gaurav | CEO | Payment of Exercise | F | 45.21 | 5,919 | 267,576 | 511,986 | 517.9 K to 512 K (-1.14 %) |
Apr 01 2021 | RCKT | ROCKET PHARMACEUTI ... | Shah Gaurav | CEO | Payment of Exercise | F | 45.94 | 7,493 | 344,235 | 517,905 | 525.4 K to 517.9 K (-1.43 %) |
Apr 01 2021 | RCKT | ROCKET PHARMACEUTI ... | Shah Gaurav | CEO | Option Exercise | M | 1.69 | 75,880 | 128,237 | 0 | |
Apr 01 2021 | RCKT | ROCKET PHARMACEUTI ... | Shah Gaurav | CEO | Payment of Exercise | F | 45.06 | 23,003 | 1,036,557 | 525,398 | 548.4 K to 525.4 K (-4.19 %) |
Apr 01 2021 | RCKT | ROCKET PHARMACEUTI ... | Shah Gaurav | CEO | Payment of Exercise | F | 44.24 | 61,350 | 2,714,320 | 548,401 | 609.8 K to 548.4 K (-10.06 %) |
Apr 01 2021 | RCKT | ROCKET PHARMACEUTI ... | Shah Gaurav | CEO | Payment of Exercise | F | 45.59 | 3,000 | 136,770 | 609,751 | 612.8 K to 609.8 K (-0.49 %) |
Apr 01 2021 | RCKT | ROCKET PHARMACEUTI ... | Shah Gaurav | CEO | Buy | M | 1.69 | 75,880 | 128,237 | 612,751 | 536.9 K to 612.8 K (+14.13 %) |
Apr 01 2021 | RCKT | ROCKET PHARMACEUTI ... | Shah Gaurav | CEO | Payment of Exercise | F | 44.34 | 8,505 | 377,105 | 536,871 | 545.4 K to 536.9 K (-1.56 %) |
Apr 01 2021 | RCKT | ROCKET PHARMACEUTI ... | Shah Gaurav | CEO | Payment of Exercise | F | 43.86 | 48,732 | 2,137,152 | 545,376 | 594.1 K to 545.4 K (-8.20 %) |
Apr 01 2021 | RCKT | ROCKET PHARMACEUTI ... | Shah Gaurav | CEO | Payment of Exercise | F | 42.80 | 8,667 | 370,906 | 594,108 | 602.8 K to 594.1 K (-1.44 %) |
Apr 01 2021 | RCKT | ROCKET PHARMACEUTI ... | Shah Gaurav | CEO | Payment of Exercise | F | 41.80 | 19,984 | 835,329 | 614,092 | 634.1 K to 614.1 K (-3.15 %) |
Mar 29 2021 | RCKT | ROCKET PHARMACEUTI ... | RTW INVESTMENTS, LP | Director | Sell | J | 0.00 | 1,344,925 | 0 | 16,185,119 | 17.5 M to 16.2 M (-7.67 %) |
Mar 26 2021 | RCKT | ROCKET PHARMACEUTI ... | Patel Kinnari | Chief Operating Off ... | Option Exercise | M | 1.69 | 38,093 | 64,377 | 0 | |
Mar 26 2021 | RCKT | ROCKET PHARMACEUTI ... | Patel Kinnari | Chief Operating Off ... | Option Exercise | M | 1.21 | 55,869 | 67,601 | 0 | |
Mar 26 2021 | RCKT | ROCKET PHARMACEUTI ... | Patel Kinnari | Chief Operating Off ... | Buy | M | 1.69 | 38,093 | 64,377 | 188,939 | 150.8 K to 188.9 K (+25.25 %) |
Mar 26 2021 | RCKT | ROCKET PHARMACEUTI ... | Patel Kinnari | Chief Operating Off ... | Buy | M | 1.21 | 55,869 | 67,601 | 150,846 | 95 K to 150.8 K (+58.82 %) |
Feb 08 2021 | RCKT | ROCKET PHARMACEUTI ... | Patel Kinnari | Chief Operating Off ... | Option Exercise | A | 62.32 | 120,000 | 7,478,400 | 120,000 | |
Feb 08 2021 | RCKT | ROCKET PHARMACEUTI ... | Militello John | See Remarks | Option Exercise | D | 62.32 | 18,000 | 1,121,760 | 18,000 | |
Feb 08 2021 | RCKT | ROCKET PHARMACEUTI ... | Shah Gaurav | President & CEO | Option Exercise | A | 62.32 | 185,000 | 11,529,200 | 185,000 | |
Feb 08 2021 | RCKT | ROCKET PHARMACEUTI ... | Schwartz Jonathan David | Chief Medical Offic ... | Option Exercise | D | 62.32 | 35,000 | 2,181,200 | 35,000 | |
Feb 03 2021 | RCKT | ROCKET PHARMACEUTI ... | Schwartz Jonathan David | Chief Medical Offic ... | Option Exercise | D | 1.21 | 213,101 | 257,852 | 38,309 | |
Feb 03 2021 | RCKT | ROCKET PHARMACEUTI ... | Schwartz Jonathan David | Chief Medical Offic ... | Option Exercise | D | 1.69 | 11,428 | 19,313 | 0 | |
Feb 03 2021 | RCKT | ROCKET PHARMACEUTI ... | Schwartz Jonathan David | Chief Medical Offic ... | Buy | M | 1.21 | 213,101 | 257,852 | 224,529 | 11.4 K to 224.5 K (+1,864.73 %) |
Feb 03 2021 | RCKT | ROCKET PHARMACEUTI ... | Schwartz Jonathan David | Chief Medical Offic ... | Buy | M | 1.69 | 11,428 | 19,313 | 11,428 | 0 to 11.4 K |
Jan 06 2021 | RCKT | ROCKET PHARMACEUTI ... | Garcia-Parada Carlos | Chief Financial Off ... | Option Exercise | A | 56.49 | 125,000 | 7,061,250 | 125,000 | |
Dec 30 2020 | RCKT | ROCKET PHARMACEUTI ... | Patel Kinnari | Chief Operating Off ... | Sell | S | 57.17 | 5,427 | 310,238 | 94,977 | 100.4 K to 95 K (-5.41 %) |
Dec 30 2020 | RCKT | ROCKET PHARMACEUTI ... | Patel Kinnari | Chief Operating Off ... | Sell | S | 56.51 | 11,334 | 640,507 | 100,404 | 111.7 K to 100.4 K (-10.14 %) |
Dec 30 2020 | RCKT | ROCKET PHARMACEUTI ... | Patel Kinnari | Chief Operating Off ... | Sell | S | 57.17 | 5,427 | 310,238 | 94,977 | 100.4 K to 95 K (-5.41 %) |
Dec 30 2020 | RCKT | ROCKET PHARMACEUTI ... | Patel Kinnari | Chief Operating Off ... | Sell | S | 56.51 | 11,334 | 640,507 | 100,404 | 111.7 K to 100.4 K (-10.14 %) |
Dec 14 2020 | RCKT | ROCKET PHARMACEUTI ... | RTW INVESTMENTS, LP | Director | Buy | P | 56.00 | 247,720 | 13,872,320 | 17,530,044 | 17.3 M to 17.5 M (+1.43 %) |
Oct 07 2020 | RCKT | ROCKET PHARMACEUTI ... | Patel Kinnari | Chief Operating Off ... | Option Exercise | A | 0.00 | 10,000 | 0 | 10,000 | |
Oct 07 2020 | RCKT | ROCKET PHARMACEUTI ... | Patel Kinnari | Chief Operating Off ... | Option Exercise | A | 0.00 | 10,000 | 0 | 10,000 | |
Sep 10 2020 | RCKT | ROCKET PHARMACEUTI ... | Patel Kinnari | Chief Operating Off ... | Option Exercise | A | 23.05 | 50,000 | 1,152,500 | 50,000 | |
Aug 05 2020 | RCKT | ROCKET PHARMACEUTI ... | Militello John | See Remarks | Option Exercise | A | 24.82 | 18,000 | 446,760 | 18,000 | |
Jun 18 2020 | RCKT | ROCKET PHARMACEUTI ... | SOUTHWELL DAVID P | Option Exercise | A | 19.90 | 20,000 | 398,000 | 20,000 | ||
Jun 18 2020 | RCKT | ROCKET PHARMACEUTI ... | SOUTHWELL DAVID P | Option Exercise | A | 19.90 | 20,000 | 398,000 | 20,000 | ||
Jun 18 2020 | RCKT | ROCKET PHARMACEUTI ... | GRANADILLO PEDRO P | Option Exercise | A | 19.90 | 20,000 | 398,000 | 20,000 | ||
Jun 18 2020 | RCKT | ROCKET PHARMACEUTI ... | GRANADILLO PEDRO P | Option Exercise | A | 19.90 | 20,000 | 398,000 | 20,000 | ||
Jun 18 2020 | RCKT | ROCKET PHARMACEUTI ... | WONG RODERICK | Option Exercise | A | 19.90 | 27,000 | 537,300 | 27,000 | ||
Jun 18 2020 | RCKT | ROCKET PHARMACEUTI ... | WONG RODERICK | Option Exercise | A | 19.90 | 27,000 | 537,300 | 27,000 | ||
Jun 18 2020 | RCKT | ROCKET PHARMACEUTI ... | Makker Gotham | Option Exercise | A | 19.90 | 3,206 | 63,799 | 3,206 | ||
Jun 18 2020 | RCKT | ROCKET PHARMACEUTI ... | Makker Gotham | Option Exercise | A | 19.90 | 3,206 | 63,799 | 3,206 | ||
Jun 18 2020 | RCKT | ROCKET PHARMACEUTI ... | Makker Gotham | Option Exercise | A | 19.90 | 9,784 | 194,702 | 9,784 | ||
Jun 18 2020 | RCKT | ROCKET PHARMACEUTI ... | Makker Gotham | Option Exercise | A | 19.90 | 9,784 | 194,702 | 9,784 | ||
Jun 18 2020 | RCKT | ROCKET PHARMACEUTI ... | Makker Gotham | Option Exercise | A | 19.90 | 20,000 | 398,000 | 20,000 | ||
Jun 18 2020 | RCKT | ROCKET PHARMACEUTI ... | Makker Gotham | Option Exercise | A | 19.90 | 20,000 | 398,000 | 20,000 | ||
Jun 18 2020 | RCKT | ROCKET PHARMACEUTI ... | Bjork Elisabeth | Option Exercise | A | 19.90 | 20,000 | 398,000 | 20,000 | ||
Jun 18 2020 | RCKT | ROCKET PHARMACEUTI ... | Bjork Elisabeth | Option Exercise | A | 19.90 | 20,000 | 398,000 | 20,000 | ||
Jun 18 2020 | RCKT | ROCKET PHARMACEUTI ... | Yalamanchi Naveen | Option Exercise | A | 19.90 | 20,000 | 398,000 | 20,000 | ||
Jun 18 2020 | RCKT | ROCKET PHARMACEUTI ... | Yalamanchi Naveen | Option Exercise | A | 19.90 | 20,000 | 398,000 | 20,000 | ||
Jun 18 2020 | RCKT | ROCKET PHARMACEUTI ... | BOESS CARSTEN | Option Exercise | A | 19.90 | 20,000 | 398,000 | 20,000 | ||
Jun 18 2020 | RCKT | ROCKET PHARMACEUTI ... | BOESS CARSTEN | Option Exercise | A | 19.90 | 20,000 | 398,000 | 20,000 | ||
Apr 22 2020 | RCKT | ROCKET PHARMACEUTI ... | Bjork Elisabeth | Option Exercise | A | 17.50 | 40,000 | 700,000 | 40,000 | ||
Mar 26 2020 | RCKT | ROCKET PHARMACEUTI ... | Shah Gaurav | President & CEO | Option Exercise | M | 0.44 | 90,925 | 40,007 | 0 | |
Mar 26 2020 | RCKT | ROCKET PHARMACEUTI ... | Shah Gaurav | President & CEO | Payment of Exercise | F | 13.78 | 32,645 | 449,848 | 1,028,997 | 1.1 M to 1 M (-3.07 %) |
Mar 26 2020 | RCKT | ROCKET PHARMACEUTI ... | Shah Gaurav | President & CEO | Buy | M | 0.43 | 90,925 | 39,098 | 1,061,642 | 970.7 K to 1.1 M (+9.37 %) |
Mar 19 2020 | RCKT | ROCKET PHARMACEUTI ... | Patel Kinnari | Chief Operating Off ... | Buy | P | 9.50 | 1,000 | 9,500 | 6,675 | 5.7 K to 6.7 K (+17.62 %) |
Feb 27 2020 | RCKT | ROCKET PHARMACEUTI ... | Shah Gaurav | President & CEO | Option Exercise | M | 0.44 | 290,000 | 127,600 | 90,925 | |
Feb 27 2020 | RCKT | ROCKET PHARMACEUTI ... | Shah Gaurav | President & CEO | Payment of Exercise | F | 20.15 | 6,233 | 125,595 | 970,717 | 977 K to 970.7 K (-0.64 %) |
Feb 27 2020 | RCKT | ROCKET PHARMACEUTI ... | Shah Gaurav | President & CEO | Buy | M | 0.43 | 290,000 | 125,628 | 976,950 | 687 K to 977 K (+42.22 %) |
Feb 10 2020 | RCKT | ROCKET PHARMACEUTI ... | Shah Gaurav | President & CEO | Option Exercise | A | 22.72 | 383,306 | 8,708,712 | 383,306 | |
Feb 10 2020 | RCKT | ROCKET PHARMACEUTI ... | Schwartz Jonathan David | Chief Medical Offic ... | Option Exercise | A | 23.89 | 7,000 | 167,230 | 7,000 | |
Feb 10 2020 | RCKT | ROCKET PHARMACEUTI ... | Schwartz Jonathan David | Chief Medical Offic ... | Option Exercise | A | 22.72 | 75,000 | 1,704,000 | 75,000 | |
Feb 10 2020 | RCKT | ROCKET PHARMACEUTI ... | Patel Kinnari | Chief Operating Off ... | Option Exercise | A | 23.89 | 15,000 | 358,350 | 15,000 | |
Feb 10 2020 | RCKT | ROCKET PHARMACEUTI ... | Patel Kinnari | Chief Operating Off ... | Option Exercise | A | 22.72 | 150,000 | 3,408,000 | 150,000 | |
Feb 10 2020 | RCKT | ROCKET PHARMACEUTI ... | Militello John | See Remarks | Option Exercise | A | 23.89 | 2,000 | 47,780 | 2,000 | |
Feb 10 2020 | RCKT | ROCKET PHARMACEUTI ... | Militello John | See Remarks | Option Exercise | A | 22.72 | 20,000 | 454,400 | 20,000 | |
Feb 10 2020 | RCKT | ROCKET PHARMACEUTI ... | Alam Kamran | SVP - Finance & PFO | Option Exercise | A | 23.89 | 3,000 | 71,670 | 3,000 | |
Feb 10 2020 | RCKT | ROCKET PHARMACEUTI ... | Alam Kamran | SVP - Finance & PFO | Option Exercise | A | 22.72 | 25,000 | 568,000 | 25,000 | |
Dec 12 2019 | RCKT | ROCKET PHARMACEUTI ... | RTW INVESTMENTS, LP | Director | Buy | P | 22.25 | 225,000 | 5,006,250 | 17,282,324 | 17.1 M to 17.3 M (+1.32 %) |
Nov 06 2019 | RCKT | ROCKET PHARMACEUTI ... | Alam Kamran | SVP - Finance & PFO | Option Exercise | A | 14.25 | 200,000 | 2,850,000 | 200,000 | |
Sep 04 2019 | RCKT | ROCKET PHARMACEUTI ... | Schwartz Jonathan David | Chief Medical Offic ... | Option Exercise | A | 10.85 | 30,000 | 325,500 | 30,000 | |
Sep 04 2019 | RCKT | ROCKET PHARMACEUTI ... | Patel Kinnari | Chief Operating Off ... | Option Exercise | A | 10.85 | 50,000 | 542,500 | 50,000 | |
Sep 04 2019 | RCKT | ROCKET PHARMACEUTI ... | Militello John | See Remarks | Option Exercise | A | 10.85 | 10,000 | 108,500 | 10,000 | |
Apr 18 2019 | RCKT | ROCKET PHARMACEUTI ... | RTW INVESTMENTS, LP | Buy | P | 17.50 | 550,005 | 9,625,088 | 17,057,324 | 16.5 M to 17.1 M (+3.33 %) | |
Mar 05 2019 | RCKT | ROCKET PHARMACEUTI ... | Shah Gaurav | See Remarks | Sell | S | 16.90 | 25,000 | 422,500 | 686,950 | 712 K to 687 K (-3.51 %) |
Mar 05 2019 | RCKT | ROCKET PHARMACEUTI ... | Shah Gaurav | See Remarks | Sell | S | 17.28 | 24,900 | 430,272 | 711,950 | 736.9 K to 712 K (-3.38 %) |
Mar 05 2019 | RCKT | ROCKET PHARMACEUTI ... | Shah Gaurav | See Remarks | Sell | S | 17.34 | 25,000 | 433,500 | 736,850 | 761.9 K to 736.9 K (-3.28 %) |
Jan 30 2019 | RCKT | ROCKET PHARMACEUTI ... | SOUTHWELL DAVID P | Option Exercise | A | 14.56 | 30,000 | 436,800 | 30,000 | ||
Jan 30 2019 | RCKT | ROCKET PHARMACEUTI ... | Schwartz Jonathan David | Chief Medical Offic ... | Option Exercise | A | 14.56 | 75,000 | 1,092,000 | 75,000 | |
Jan 30 2019 | RCKT | ROCKET PHARMACEUTI ... | GRANADILLO PEDRO P | Option Exercise | A | 14.56 | 30,000 | 436,800 | 30,000 | ||
Jan 30 2019 | RCKT | ROCKET PHARMACEUTI ... | BOESS CARSTEN | Option Exercise | A | 14.56 | 30,000 | 436,800 | 30,000 | ||
Jan 30 2019 | RCKT | ROCKET PHARMACEUTI ... | Makker Gotham | Option Exercise | A | 14.56 | 4,666 | 67,937 | 4,666 | ||
Jan 30 2019 | RCKT | ROCKET PHARMACEUTI ... | Makker Gotham | Option Exercise | A | 14.56 | 30,000 | 436,800 | 30,000 | ||
Jan 30 2019 | RCKT | ROCKET PHARMACEUTI ... | Militello John | See Remarks | Option Exercise | A | 14.56 | 20,000 | 291,200 | 20,000 | |
Jan 30 2019 | RCKT | ROCKET PHARMACEUTI ... | Yalamanchi Naveen | Option Exercise | A | 14.56 | 30,000 | 436,800 | 30,000 | ||
Jan 30 2019 | RCKT | ROCKET PHARMACEUTI ... | WONG RODERICK | Option Exercise | A | 14.56 | 40,500 | 589,680 | 40,500 | ||
Jan 30 2019 | RCKT | ROCKET PHARMACEUTI ... | Shah Gaurav | See Remarks | Option Exercise | A | 14.56 | 315,700 | 4,596,592 | 315,700 | |
Jan 30 2019 | RCKT | ROCKET PHARMACEUTI ... | Patel Kinnari | Chief Operating Off ... | Option Exercise | A | 14.56 | 180,000 | 2,620,800 | 180,000 | |
Dec 28 2018 | RCKT | ROCKET PHARMACEUTI ... | WONG RODERICK | Grant | A | 13.93 | 100,000 | 1,393,000 | 16,507,319 | 16.4 M to 16.5 M (+0.61 %) | |
Dec 21 2018 | RCKT | ROCKET PHARMACEUTI ... | Patel Kinnari | Chief Operating Off ... | Option Exercise | M | 1.21 | 55,869 | 67,601 | 111,738 | |
Dec 21 2018 | RCKT | ROCKET PHARMACEUTI ... | Patel Kinnari | Chief Operating Off ... | Buy | M | 1.21 | 55,869 | 67,601 | 55,869 | 0 to 55.9 K |
Dec 14 2018 | RCKT | ROCKET PHARMACEUTI ... | SOUTHWELL DAVID P | Sell | S | 15.19 | 38,768 | 588,886 | 95,160 | 133.9 K to 95.2 K (-28.95 %) | |
Dec 10 2018 | RCKT | ROCKET PHARMACEUTI ... | SOUTHWELL DAVID P | Option Exercise | M | 0.00 | 65,625 | 0 | 0 | ||
Dec 10 2018 | RCKT | ROCKET PHARMACEUTI ... | SOUTHWELL DAVID P | Sell | S | 14.91 | 4,923 | 73,402 | 133,928 | 138.9 K to 133.9 K (-3.55 %) | |
Dec 10 2018 | RCKT | ROCKET PHARMACEUTI ... | SOUTHWELL DAVID P | Sell | S | 15.15 | 52,809 | 800,056 | 138,851 | 191.7 K to 138.9 K (-27.55 %) | |
Dec 10 2018 | RCKT | ROCKET PHARMACEUTI ... | SOUTHWELL DAVID P | Buy | M | 0.00 | 153,125 | 0 | 191,660 | 38.5 K to 191.7 K (+397.37 %) | |
Dec 10 2018 | RCKT | ROCKET PHARMACEUTI ... | Patel Kinnari | Chief Operating Off ... | Buy | P | 14.98 | 5,675 | 85,012 | 5,675 | 0 to 5.7 K |
Nov 29 2018 | RCKT | ROCKET PHARMACEUTI ... | WONG RODERICK | Grant | A | 15.50 | 967,742 | 15,000,001 | 16,407,319 | 15.4 M to 16.4 M (+6.27 %) | |
Aug 29 2018 | RCKT | ROCKET PHARMACEUTI ... | RTW INVESTMENTS, LP | Option Exercise | J | 22.05 | 1 | 22 | 1 | ||
Aug 29 2018 | RCKT | ROCKET PHARMACEUTI ... | RTW INVESTMENTS, LP | Option Exercise | J | 22.05 | 1 | 22 | 1 | ||
Aug 03 2018 | RCKT | ROCKET PHARMACEUTI ... | Yalamanchi Naveen | Sell | S | 22.00 | 637 | 14,014 | 113,641 | 114.3 K to 113.6 K (-0.56 %) | |
Jun 28 2018 | RCKT | ROCKET PHARMACEUTI ... | Militello John | See Remarks | Option Exercise | A | 20.61 | 10,000 | 206,100 | 10,000 | |
Apr 02 2018 | RCKT | ROCKET PHARMACEUTI ... | WONG RODERICK | Director | Option Exercise | A | 18.75 | 47,000 | 881,250 | 47,000 | |
Apr 02 2018 | RCKT | ROCKET PHARMACEUTI ... | SOUTHWELL DAVID P | Director | Option Exercise | M | 0.00 | 21,875 | 0 | 65,625 | |
Apr 02 2018 | RCKT | ROCKET PHARMACEUTI ... | SOUTHWELL DAVID P | Director | Option Exercise | A | 18.75 | 40,000 | 750,000 | 40,000 | |
Apr 02 2018 | RCKT | ROCKET PHARMACEUTI ... | SOUTHWELL DAVID P | Director | Buy | M | 0.00 | 21,875 | 0 | 38,535 | 16.7 K to 38.5 K (+131.30 %) |
Apr 02 2018 | RCKT | ROCKET PHARMACEUTI ... | Yalamanchi Naveen | Director | Option Exercise | A | 18.75 | 40,000 | 750,000 | 40,000 | |
Apr 02 2018 | RCKT | ROCKET PHARMACEUTI ... | GRANADILLO PEDRO P | Director | Option Exercise | A | 18.75 | 40,000 | 750,000 | 40,000 | |
Apr 02 2018 | RCKT | ROCKET PHARMACEUTI ... | BOESS CARSTEN | Director | Option Exercise | A | 18.75 | 40,000 | 750,000 | 40,000 | |
Apr 02 2018 | RCKT | ROCKET PHARMACEUTI ... | Shah Gaurav | See Remarks | Option Exercise | A | 18.75 | 395,000 | 7,406,250 | 395,000 | |
Apr 02 2018 | RCKT | ROCKET PHARMACEUTI ... | Makker Gotham | Director | Option Exercise | A | 18.75 | 3,300 | 61,875 | 3,300 | |
Apr 02 2018 | RCKT | ROCKET PHARMACEUTI ... | Makker Gotham | Director | Option Exercise | A | 18.75 | 40,000 | 750,000 | 40,000 | |
Apr 02 2018 | RCKT | ROCKET PHARMACEUTI ... | Patel Kinnari | Chief Operating Off ... | Option Exercise | A | 18.75 | 175,000 | 3,281,250 | 175,000 | |
Apr 02 2018 | RCKT | ROCKET PHARMACEUTI ... | Militello John | See Remarks | Option Exercise | A | 18.75 | 10,000 | 187,500 | 10,000 | |
Apr 02 2018 | RCKT | ROCKET PHARMACEUTI ... | Schwartz Jonathan David | Chief Medical Offic ... | Option Exercise | A | 18.75 | 60,000 | 1,125,000 | 60,000 | |
Sep 18 2017 | ITEK | INOTEK PHARMACEUTI ... | RITTER DALE | Vice President, Fin ... | Option Exercise | M | 0.00 | 12,500 | 0 | 37,500 | |
Sep 18 2017 | ITEK | INOTEK PHARMACEUTI ... | RITTER DALE | Vice President, Fin ... | Buy | M | 0.00 | 12,500 | 0 | 19,827 | 7.3 K to 19.8 K (+170.60 %) |
Jun 21 2017 | ITEK | INOTEK PHARMACEUTI ... | BARBERICH TIMOTHY J | Director | Option Exercise | A | 1.80 | 45,000 | 81,000 | 45,000 | |
Jun 21 2017 | ITEK | INOTEK PHARMACEUTI ... | BOESS CARSTEN | Director | Option Exercise | A | 1.80 | 45,000 | 81,000 | 45,000 | |
Jun 21 2017 | ITEK | INOTEK PHARMACEUTI ... | HOWES PAUL G | Director | Option Exercise | A | 1.80 | 45,000 | 81,000 | 45,000 | |
Jun 21 2017 | ITEK | INOTEK PHARMACEUTI ... | Phillips Gary M. | Director | Option Exercise | A | 1.80 | 45,000 | 81,000 | 45,000 | |
Jun 21 2017 | ITEK | INOTEK PHARMACEUTI ... | CARROLL J MARTIN | Director | Option Exercise | A | 1.80 | 45,000 | 81,000 | 45,000 | |
Jun 21 2017 | ITEK | INOTEK PHARMACEUTI ... | Machado Patrick | Director | Option Exercise | A | 1.80 | 45,000 | 81,000 | 45,000 | |
Jun 21 2017 | ITEK | INOTEK PHARMACEUTI ... | Spivey Richard N. | Director | Option Exercise | A | 1.80 | 45,000 | 81,000 | 45,000 | |
Jan 24 2017 | ITEK | INOTEK PHARMACEUTI ... | SOUTHWELL DAVID P | President and CEO | Option Exercise | A | 0.00 | 350,000 | 0 | 350,000 | |
Jan 24 2017 | ITEK | INOTEK PHARMACEUTI ... | SOUTHWELL DAVID P | President and CEO | Option Exercise | A | 0.00 | 350,000 | 0 | 350,000 | |
Jan 24 2017 | ITEK | INOTEK PHARMACEUTI ... | Baumgartner Rudolf A | See Remarks | Option Exercise | A | 0.00 | 175,000 | 0 | 175,000 | |
Jan 24 2017 | ITEK | INOTEK PHARMACEUTI ... | Baumgartner Rudolf A | See Remarks | Option Exercise | A | 0.00 | 120,000 | 0 | 120,000 | |
Jan 19 2017 | ITEK | INOTEK PHARMACEUTI ... | RITTER DALE | Vice President, Fin ... | Option Exercise | A | 0.00 | 50,000 | 0 | 50,000 | |
Jan 09 2017 | ITEK | INOTEK PHARMACEUTI ... | SOUTHWELL DAVID P | President and CEO | Buy | P | 1.75 | 60,000 | 105,000 | 62,765 | 2.8 K to 62.8 K (+2,169.98 %) |
Jan 06 2017 | ITEK | INOTEK PHARMACEUTI ... | DEVON PARK BIOVENTURES LP | 10% Owner | Sell | J | 0.00 | 9,857 | 0 | 0 | 9.9 K to 0 (-100.00 %) |
Jan 06 2017 | ITEK | INOTEK PHARMACEUTI ... | DEVON PARK BIOVENTURES LP | 10% Owner | Sell | J | 0.00 | 3,243,709 | 0 | 9,857 | 3.3 M to 9.9 K (-99.70 %) |
Sep 29 2016 | ITEK | INOTEK PHARMACEUTI ... | BARBERICH TIMOTHY J | Director | Option Exercise | A | 9.49 | 24,000 | 227,760 | 24,000 | |
Aug 18 2016 | ITEK | INOTEK PHARMACEUTI ... | Machado Patrick | Director | Option Exercise | A | 6.91 | 24,000 | 165,840 | 24,000 | |
Jun 27 2016 | ITEK | INOTEK PHARMACEUTI ... | Phillips Gary M. | Director | Option Exercise | A | 7.61 | 12,000 | 91,320 | 12,000 | |
Jun 27 2016 | ITEK | INOTEK PHARMACEUTI ... | BOESS CARSTEN | Director | Option Exercise | A | 7.61 | 12,000 | 91,320 | 12,000 | |
Jun 27 2016 | ITEK | INOTEK PHARMACEUTI ... | CARROLL J MARTIN | Director | Option Exercise | A | 7.61 | 51,000 | 388,110 | 51,000 | |
Jun 27 2016 | ITEK | INOTEK PHARMACEUTI ... | CARROLL J MARTIN | Director | Option Exercise | A | 7.61 | 12,000 | 91,320 | 12,000 | |
Jun 27 2016 | ITEK | INOTEK PHARMACEUTI ... | HOWES PAUL G | Director | Option Exercise | A | 7.61 | 12,000 | 91,320 | 12,000 | |
Jun 27 2016 | ITEK | INOTEK PHARMACEUTI ... | Spivey Richard N. | Director | Option Exercise | A | 7.61 | 12,000 | 91,320 | 12,000 |